TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Sino Swed Biotech AB
Closing information (x1000 EUR)
| Closing information | 2025/04 | 2024/04 | 2023/04 |
| Turnover |
91
|
142
|
133 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-4
|
41
|
31 |
| EBITDA |
-4
|
41
|
31 |
| Total assets |
47
|
79
|
69 |
| Current assets |
37
|
79
|
69 |
| Current liabilities |
-5
|
0
|
5 |
| Equity capital |
45
|
68
|
55 |
| - share capital |
9
|
9
|
9 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2025/04 | 2024/04 | 2023/04 |
| Solvency |
95.7%
|
86.1%
|
79.7% |
| Turnover per employee |
46
|
71
|
66 |
| Profit as a percentage of turnover |
-4.4%
|
28.9%
|
23.3% |
| Return on assets (ROA) |
-8.5%
|
51.9%
|
44.9% |
| Current ratio | -740.0% | 1380.0% | |
| Return on equity (ROE) |
-8.9%
|
60.3%
|
56.4% |
| Change turnover |
-61
|
13
|
-15 |
| Change turnover % |
-40%
|
10%
|
-10% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/04 | 2024/04 | 2023/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.